Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oniyx Therapeutics IncfiledCriticalOniyx Therapeutics Inc
Priority to CU20110091ApriorityCriticalpatent/CU20110091A7/es
Publication of CU20110091A7publicationCriticalpatent/CU20110091A7/es
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La invención proporciona terapia de combinación, donde uno o más de otros terapéuticos se administran con epoxicetonas peptídicas o una sal farmacéuticamente aceptable de las mismas. Otros aspectos de la invención se refiere al tratamiento del cáncer con una epoxicetona peptídica administrada junto con otro agente terapéutico.
CU20110091A2011-04-212011-04-21Terapia de combinación con epoxicetonas peptídicas
CU20110091A7
(es)
Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viii